ANDREW CORBIN: Open Payments
NPI 1871078501 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 29 payments from 10 companies in 2025. Trend: 2023 $219 · 2024 $596 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $188 |
| Alkermes, Inc. | 3 | $66 |
| Lundbeck LLC | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| HARMONY BIOSCIENCES LLC | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: COBENFY, REXULTI, ARISTADA, VRAYLAR, Jornay PM, WAKIX, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across NE — which companies pay providers there.
